J. Paul Taylor (physician)

Last updated

J. Paul Taylor is an American physician scientist and research hospital director known for his contributions to the fields of neurogenetics, RNA biology, and neurological disease, [1] including the role of biomolecular condensation in neurological diseases such as ALS. [2]

Contents

Taylor is Scientific Director and Executive Vice President of St. Jude Children's Research Hospital in Memphis, Tennessee. [3] He holds the Edward F. Barry Endowed Chair in Cell and Molecular Biology and also serves as Chair of the Department of Cell and Molecular Biology [4] and Director of the St. Jude Pediatric Translational Neuroscience Initiative. [5] [6]

He is a fellow of the American Neurological Association and the Association of American Physicians, [7] the winner of the 2020 Norman Saunders International Research Prize, [8] and the winner of the 2020 Potamkin Prize. [9] From 2015 to 2022 Taylor was an Investigator of the Howard Hughes Medical Institute. [10]

Education

Taylor graduated with a Bachelor of Science in Physiology from the University of California, Davis. He obtained his MD and PhD from Jefferson Medical College of Thomas Jefferson University. He completed his medical internship and neurology residency at the University of Pennsylvania School of Medicine, followed by a fellowship in neurogenetics at the National Institute of Neurological Disorders and Stroke in the lab of Kenneth Fischbeck. [1]

Career

Taylor joined the faculty at the University of Pennsylvania School of Medicine in 2004 as Assistant Professor of Neurology, where he established a research program investigating the molecular mechanisms of neurodegenerative disease. [1] In 2008, Taylor moved to St. Jude Children's Research Hospital as Associate Member in the Department of Developmental Neurobiology. [11] In 2014, Taylor became the founding Chair of the Department of Cell and Molecular Biology. [11] In 2015, Taylor was named an Investigator of the Howard Hughes Medical Institute, a position he held until 2022 when he was named Scientific Director and Executive Vice President of St. Jude. [10] Taylor is also the founding director of the St. Jude Pediatric Translational Neuroscience Initiative, [5] a program that leverages the hospital's infrastructure in research and experimental therapeutics to develop cures for childhood neurological diseases.

Taylor's research program at St. Jude focuses on neurogenetics, the biology of RNA and RNA-binding proteins, and mechanisms of neurological disease, with particular interest in the role of biomolecular condensation in diseases such as ALS and frontotemporal dementia. [6] He was named on the Clarivate list of Highly Cited Researchers in 2019, 2020, 2021, 2022, and 2023. [12] [13]

Selected research papers

Related Research Articles

The Kolling Institute is located in the grounds of the Royal North Shore Hospital in St Leonards, Sydney Australia. The institute, founded in 1920, is the oldest medical research institute in New South Wales.

Sir John Anthony Hardy is a human geneticist and molecular biologist at the Reta Lila Weston Institute of Neurological Studies at University College London with research interests in neurological diseases.

Bart De Strooper is a Belgian molecular biologist and professor at Vlaams Instituut voor Biotechnologie and KU Leuven and the UK Dementia Research Institute and University College London, UK. De Strooper's research seeks to translate genetic data into the identification and treatment of neurodegenerative diseases and treatments. interest are the secretases, proteases which cleave the amyloid precursor protein (APP), resulting in amyloid peptides.

<span class="mw-page-title-main">Gregory Petsko</span> American biochemist and academic

Gregory A. Petsko is an American biochemist and member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society. He is currently Professor of Neurology at the Ann Romney Center for Neurologic Diseases at Harvard Medical School and Brigham and Women's Hospital. He formerly had an endowed professorship in Neurology and Neuroscience at Weill Cornell Medical College and is still an adjunct professor of Biomedical Engineering at Cornell University, and is also the Gyula and Katica Tauber Professor, Emeritus, in biochemistry and chemistry at Brandeis University. On October 24, 2023, in a ceremony in the East Room of the White House, President Joe Biden presented Gregory Petsko and eight others with the National Medal of Science, the highest honor the United States can bestow on a scientist and engineer.

<span class="mw-page-title-main">Neurogenetics</span> Study of role of genetics in the nervous system

Neurogenetics studies the role of genetics in the development and function of the nervous system. It considers neural characteristics as phenotypes, and is mainly based on the observation that the nervous systems of individuals, even of those belonging to the same species, may not be identical. As the name implies, it draws aspects from both the studies of neuroscience and genetics, focusing in particular how the genetic code an organism carries affects its expressed traits. Mutations in this genetic sequence can have a wide range of effects on the quality of life of the individual. Neurological diseases, behavior and personality are all studied in the context of neurogenetics. The field of neurogenetics emerged in the mid to late 20th century with advances closely following advancements made in available technology. Currently, neurogenetics is the center of much research utilizing cutting edge techniques.

John Quinn Trojanowski was an American academic research neuroscientist specializing in neurodegeneration. He and his partner, Virginia Man-Yee Lee, MBA, Ph.D., are noted for identifying the roles of three proteins in neurodegenerative diseases: tau in Alzheimer's disease, alpha-synuclein in Parkinson's disease, and TDP-43 in Amyotrophic Lateral Sclerosis (ALS) and frontotemporal degeneration.

Avindra "Avi" Nath, is a physician-scientist who specializes in neuroimmunology. Nath is a senior investigator, and intramural clinical director of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) in the United States. At NINDS, Nath also leads the Section of Infections of the Nervous System and plans to institute a translational research center. He previously served in several research and administrative positions at the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine.

<span class="mw-page-title-main">Gladstone Institutes</span>

Gladstone Institutes is an independent, non-profit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease. Its researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.

David Chaim Rubinsztein FRS FMedSci is the Deputy Director of the Cambridge Institute of Medical Research (CIMR), Professor of Molecular Neurogenetics at the University of Cambridge and a UK Dementia Research Institute Professor.

Charles J. Sherr is the chair of the Tumor Cell Biology Department at St. Jude Children's Research Hospital. He studies tumor suppressor genes and cell division.

There are more than 25 genes known to be associated with amyotrophic lateral sclerosis (ALS) as of June 2018, which collectively account for about 70% of cases of familial ALS (fALS) and 10% of cases of sporadic ALS (sALS). About 5–10% of cases of ALS are directly inherited. Overall, first-degree relatives of an individual with ALS have a 1% risk of developing ALS. ALS has an oligogenic mode of inheritance, meaning that mutations in two or more genes are required to cause disease.

Jeffrey D. Macklis is an American neuroscientist. He is the Max and Anne Wien Professor of Life Sciences in the Department of Stem Cell and Regenerative Biology and Center for Brain Science at Harvard University, Professor of Neurology [Neuroscience] at Harvard Medical School, and on the Executive Committee and a Member of the Principal Faculty of the Neuroscience / Nervous System Diseases Program at the Harvard Stem Cell Institute.

<span class="mw-page-title-main">Richard Gilbertson</span> British paediatric oncology clinician scientist

Professor Richard James Gilbertson is a paediatric oncology clinician scientist and a Senior Group Leader at the Cancer Research UK Cambridge Institute, University of Cambridge. He is the Li Ka Shing Chair of Oncology, and Director of the CRUK Cambridge Major Centre and the Children's Brain Tumour Centre of Excellence.

<span class="mw-page-title-main">Thirumala-Devi Kanneganti</span> Indian immunologist

Thirumala-Devi Kanneganti is an immunologist and is the Rose Marie Thomas Endowed Chair, Vice Chair of the Department of Immunology, and Member at St. Jude Children's Research Hospital. She is also Director of the Center of Excellence in Innate Immunity and Inflammation at St. Jude Children's Research Hospital. Her research interests include investigating fundamental mechanisms of innate immunity, including inflammasomes and inflammatory cell death, PANoptosis, in infectious and inflammatory disease and cancer.

<span class="mw-page-title-main">Bradlee Heckmann</span>

Bradlee L. Heckmann is an American biologist, pharmacologist. Heckmann holds academic appointments as a neuroimmunologist at the Byrd Alzheimer's Center and USF Health Neuroscience Institute and is assistant professor in molecular medicine at the USF Health Morsani College of Medicine. Heckmann's research has been focused on understanding the regulation of inflammatory and metabolic processes in the central nervous system, with particular emphasis on neurodegenerative diseases including Alzheimer's disease and the role of the autophagy machinery in this setting.

Anne Cross is an American neurologist and neuroimmunologist and the Section Head of Neuroimmunology at Washington University School of Medicine in St. Louis, Missouri. Cross holds the Manny and Rosalyn Rosenthal–Dr. John L. Trotter Endowed Chair in Neuroimmunology at WUSTL School of Medicine and co-directs the John L Trotter Multiple Sclerosis Clinic at Barnes-Jewish Hospital. Cross is a leader in the field of neuroimmunology and was the first to discover the role of B cells in the pathogenesis of multiple sclerosis in animals and then in humans. Cross now develops novel imaging techniques to observe inflammation and demyelination in the central nervous systems of MS patients for diagnosis and disease management.

<span class="mw-page-title-main">Robert K. Naviaux</span> American scientist

Robert K. Naviaux is an American physician-scientist who specializes in mitochondrial medicine and complex chronic disorders. He discovered the cause of Alpers syndrome, and was part of the team that reported the first mitochondrial DNA (mtDNA) mutation to cause genetic forms of autism. Naviaux proposed the cell danger response (CDR) and hyperpurinergia hypothesis for complex disorders in 2014 and directed the first FDA-approved clinical trial to study the safety and efficacy of the antipurinergic drug suramin as a new treatment for autism spectrum disorder (ASD).

Dennis J. Selkoe is an American physician (neurologist) known for his research into the molecular basis of Alzheimer's disease. In 1985 he became Co-Director of the Center for Neurological Diseases and from 1990, Vincent and Stella Coates Professor of Neurological Diseases at Harvard Medical School. He is also a Fellow of the AAAS and a member of the National Academy of Medicine.

James R. Downing is an American clinical executive. He is the president and chief executive officer of St. Jude Children's Research Hospital.

Professor Patrick Francis Chinnery, FRCP, FRCPath, FMedSci, is a neurologist, clinician scientist, and Wellcome Trust Principal Research Fellow based in the Medical Research Council Mitochondrial Biology Unit and the University of Cambridge, where he is also Professor of Neurology and Head of the Department of Clinical Neurosciences.

References

  1. 1 2 3 "Q&A - J. Paul Taylor" (PDF). Neuron.
  2. ↑ "New Clues To ALS And Alzheimer's Disease From Physics". NPR . 2020. Retrieved 2023-10-20.
  3. ↑ "J. Paul Taylor, M.D., Ph.D., named scientific director and executive vice president of St. Jude". www.stjude.org. Retrieved 2023-10-20.
  4. ↑ "Cell and Molecular Biology". St. Jude Research. Retrieved 2023-10-20.
  5. 1 2 "Pediatric Translational Neuroscience Initiative". St. Jude Research.
  6. 1 2 "J. Paul Taylor, MD, PhD". www.stjude.org. Retrieved 2023-10-20.
  7. ↑ "Association of American Physicians". aap-online.org. Retrieved 2023-10-20.
  8. ↑ "The Jacob's Ladder Norman Saunders International Research Prize: J. Paul Taylor, MD, PhD | Jacobs Ladder" . Retrieved 2023-10-20.
  9. ↑ "Potamkin Prize for Research - 2020 - J. Paul Taylor, MD, PHD". American Brain Foundation. Retrieved 2023-10-20.
  10. 1 2 "J. Paul Taylor". HHMI. Retrieved 2023-10-20.
  11. 1 2 Hospital, St Jude Children's Research. "St. Jude Children's Research Hospital adding department and faculty to aid mission". www.prnewswire.com (Press release). Retrieved 2023-10-20.
  12. ↑ "Past lists". Clarivate. Retrieved 2023-10-20.
  13. ↑ "Highly Cited Researchers". Clarivate. Retrieved 2023-11-20.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.